- Home
- IPHA vs ACR Comparison
IPHA vs ACR Comparison
Compare IPHA & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | ACR |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 143.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | ACR |
|---|---|---|
| Price | $1.85 | $23.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $5.00 | ★ $24.50 |
| AVG Volume (30 Days) | 22.5K | ★ 48.1K |
| Earning Date | 09-17-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | N/A | ★ 0.95 |
| Revenue | $14,839,695.00 | ★ $88,952,000.00 |
| Revenue This Year | $22.29 | $4.05 |
| Revenue Next Year | $43.90 | $0.38 |
| P/E Ratio | ★ N/A | $24.90 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $1.47 | $14.94 |
| 52 Week High | $3.51 | $24.17 |
Technical Indicators
Market Signals| Indicator | IPHA | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 68.64 |
| Support Level | $1.85 | $22.74 |
| Resistance Level | $1.92 | $24.17 |
| Average True Range (ATR) | 0.07 | 0.93 |
| MACD | 0.00 | 0.24 |
| Stochastic Oscillator | 25.58 | 89.41 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.